IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 252 filers reported holding IMMUNOMEDICS INC in Q4 2019. The put-call ratio across all filers is 0.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $134,167,000 | +126.9% | 1,577,880 | -5.4% | 13.75% | +99.5% |
| Q2 2020 | $59,140,000 | +117.5% | 1,668,740 | -17.3% | 6.89% | +48.4% |
| Q1 2020 | $27,191,000 | +3.2% | 2,017,103 | +62.0% | 4.64% | +37.8% |
| Q4 2019 | $26,349,000 | +58.9% | 1,245,243 | -0.4% | 3.37% | +34.3% |
| Q3 2019 | $16,582,000 | -2.3% | 1,250,536 | +2.2% | 2.51% | +6.4% |
| Q2 2019 | $16,970,000 | -37.1% | 1,223,483 | -12.9% | 2.36% | -32.8% |
| Q1 2019 | $26,985,000 | +39.0% | 1,404,713 | +3.3% | 3.51% | +13.3% |
| Q4 2018 | $19,411,000 | -19.1% | 1,360,280 | +18.1% | 3.10% | -20.0% |
| Q3 2018 | $23,988,000 | -12.4% | 1,151,622 | -0.5% | 3.87% | -9.3% |
| Q2 2018 | $27,398,000 | +83.9% | 1,157,498 | +13.5% | 4.27% | +30.4% |
| Q1 2018 | $14,901,000 | -2.4% | 1,019,920 | +8.0% | 3.27% | -21.8% |
| Q4 2017 | $15,262,000 | -16.8% | 944,404 | -28.0% | 4.18% | -27.9% |
| Q3 2017 | $18,335,000 | +1.4% | 1,311,514 | -36.0% | 5.81% | -4.3% |
| Q2 2017 | $18,090,000 | +33.4% | 2,048,643 | -2.3% | 6.07% | +17.2% |
| Q1 2017 | $13,564,000 | +62.0% | 2,096,495 | -8.1% | 5.18% | +40.7% |
| Q4 2016 | $8,375,000 | +159.5% | 2,282,009 | +129.8% | 3.68% | +165.0% |
| Q3 2016 | $3,227,000 | +40.8% | 992,867 | +0.5% | 1.39% | +30.8% |
| Q2 2016 | $2,292,000 | -40.6% | 987,854 | -36.0% | 1.06% | -45.5% |
| Q1 2016 | $3,859,000 | +47.7% | 1,543,542 | +81.4% | 1.95% | +78.0% |
| Q4 2015 | $2,612,000 | – | 850,757 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|